
David Lukton
Examiner (ID: 4076, Phone: (571)272-0952 , Office: P/1676 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1811, 1611, 1676, 1654, 1658, 1653 |
| Total Applications | 1846 |
| Issued Applications | 1076 |
| Pending Applications | 177 |
| Abandoned Applications | 596 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6349361
[patent_doc_number] => 20100249033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'POLYMER FACTOR IX MOIETY CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 12/795461
[patent_app_country] => US
[patent_app_date] => 2010-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22219
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20100249033.pdf
[firstpage_image] =>[orig_patent_app_number] => 12795461
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/795461 | POLYMER FACTOR IX MOIETY CONJUGATES | Jun 6, 2010 | Abandoned |
Array
(
[id] => 6596539
[patent_doc_number] => 20100292135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'INHIBITORS OF RecA ACTIVITIES FOR CONTROL OF ANTIBIOTIC-RESISTANT BACTERIAL PATHOGENS'
[patent_app_type] => utility
[patent_app_number] => 12/790407
[patent_app_country] => US
[patent_app_date] => 2010-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 33830
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20100292135.pdf
[firstpage_image] =>[orig_patent_app_number] => 12790407
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/790407 | INHIBITORS OF RecA ACTIVITIES FOR CONTROL OF ANTIBIOTIC-RESISTANT BACTERIAL PATHOGENS | May 27, 2010 | Abandoned |
Array
(
[id] => 6347559
[patent_doc_number] => 20100330645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'ONE POT DESIALYLATION AND GLYCOPEGYLATION OF THERAPEUTIC PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/784323
[patent_app_country] => US
[patent_app_date] => 2010-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 66
[patent_figures_cnt] => 66
[patent_no_of_words] => 43020
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0330/20100330645.pdf
[firstpage_image] =>[orig_patent_app_number] => 12784323
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/784323 | One pot desialylation and glycopegylation of therapeutic peptides | May 19, 2010 | Issued |
Array
(
[id] => 7808192
[patent_doc_number] => 20120059146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'METHOD FOR THE PREPARATION OF CYCLOPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/264064
[patent_app_country] => US
[patent_app_date] => 2010-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5497
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20120059146.pdf
[firstpage_image] =>[orig_patent_app_number] => 13264064
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/264064 | Method for the preparation of cyclopeptides | May 5, 2010 | Issued |
Array
(
[id] => 5993801
[patent_doc_number] => 20110015371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'Inhibitors of interleukin-1 beta converting enzyme'
[patent_app_type] => utility
[patent_app_number] => 12/800046
[patent_app_country] => US
[patent_app_date] => 2010-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56839
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20110015371.pdf
[firstpage_image] =>[orig_patent_app_number] => 12800046
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/800046 | Inhibitors of interleukin-1 beta converting enzyme | May 4, 2010 | Abandoned |
Array
(
[id] => 8527823
[patent_doc_number] => 08304393
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-06
[patent_title] => 'Epithelial cell growth promoter'
[patent_app_type] => utility
[patent_app_number] => 12/662761
[patent_app_country] => US
[patent_app_date] => 2010-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 15
[patent_no_of_words] => 7250
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12662761
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/662761 | Epithelial cell growth promoter | May 2, 2010 | Issued |
Array
(
[id] => 6582998
[patent_doc_number] => 20100291179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'COMPOSITE BIOMATERIAL FOR CONTROLLED RELEASE OF ACTIVE INGREDIENTS'
[patent_app_type] => utility
[patent_app_number] => 12/762230
[patent_app_country] => US
[patent_app_date] => 2010-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7142
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20100291179.pdf
[firstpage_image] =>[orig_patent_app_number] => 12762230
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/762230 | COMPOSITE BIOMATERIAL FOR CONTROLLED RELEASE OF ACTIVE INGREDIENTS | Apr 15, 2010 | Abandoned |
Array
(
[id] => 6163774
[patent_doc_number] => 20110160431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'PRODUCTION OF PEPTIDES CONTAINING POLY-GLY SEQUENCES USING FMOC CHEMISTRY'
[patent_app_type] => utility
[patent_app_number] => 12/996770
[patent_app_country] => US
[patent_app_date] => 2010-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5375
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20110160431.pdf
[firstpage_image] =>[orig_patent_app_number] => 12996770
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/996770 | PRODUCTION OF PEPTIDES CONTAINING POLY-GLY SEQUENCES USING FMOC CHEMISTRY | Mar 28, 2010 | Abandoned |
Array
(
[id] => 6188013
[patent_doc_number] => 20110171304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'INJECTABLE BETA-HAIRPIN PEPTIDE HYDROGEL THAT KILLS METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS'
[patent_app_type] => utility
[patent_app_number] => 12/730656
[patent_app_country] => US
[patent_app_date] => 2010-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 5077
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20110171304.pdf
[firstpage_image] =>[orig_patent_app_number] => 12730656
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/730656 | Injectable β-hairpin peptide hydrogel that kills methicillin-resistant Staphylococcus aureus | Mar 23, 2010 | Issued |
Array
(
[id] => 7818746
[patent_doc_number] => 20120065366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'CYCLIC AMINO ACID MOLECULES AND METHODS OF PREPARING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/257159
[patent_app_country] => US
[patent_app_date] => 2010-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 16807
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20120065366.pdf
[firstpage_image] =>[orig_patent_app_number] => 13257159
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/257159 | Cyclic amino acid molecules and methods of preparing the same | Mar 15, 2010 | Issued |
Array
(
[id] => 7756649
[patent_doc_number] => 20120028879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'HIGHLY SENSITIVE DETECTION METHOD FOR HIGHLY VIRULENT ORAL CAVITY BACTERIA'
[patent_app_type] => utility
[patent_app_number] => 13/260840
[patent_app_country] => US
[patent_app_date] => 2010-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 20440
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20120028879.pdf
[firstpage_image] =>[orig_patent_app_number] => 13260840
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/260840 | HIGHLY SENSITIVE DETECTION METHOD FOR HIGHLY VIRULENT ORAL CAVITY BACTERIA | Mar 14, 2010 | Abandoned |
Array
(
[id] => 7767835
[patent_doc_number] => 20120035098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'NOVEL ANTIVIRAL AGENT'
[patent_app_type] => utility
[patent_app_number] => 13/254502
[patent_app_country] => US
[patent_app_date] => 2010-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12673
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20120035098.pdf
[firstpage_image] =>[orig_patent_app_number] => 13254502
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/254502 | Antiviral agent | Mar 3, 2010 | Issued |
Array
(
[id] => 6048421
[patent_doc_number] => 20110207665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'METHOD OF REGULATING PROLIFERATION AND DIFFERENTIATION OF KERATINOCYES'
[patent_app_type] => utility
[patent_app_number] => 13/127058
[patent_app_country] => US
[patent_app_date] => 2010-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 31219
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20110207665.pdf
[firstpage_image] =>[orig_patent_app_number] => 13127058
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/127058 | Method of regulating proliferation and differentiation of keratinocyes | Feb 27, 2010 | Issued |
Array
(
[id] => 6237459
[patent_doc_number] => 20100267938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'USE OF ANTIBODY-SURROGATE ANTIGEN SYSTEMS FOR DETECTION OF ANALYTES'
[patent_app_type] => utility
[patent_app_number] => 12/705746
[patent_app_country] => US
[patent_app_date] => 2010-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11635
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267938.pdf
[firstpage_image] =>[orig_patent_app_number] => 12705746
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/705746 | USE OF ANTIBODY-SURROGATE ANTIGEN SYSTEMS FOR DETECTION OF ANALYTES | Feb 14, 2010 | Abandoned |
Array
(
[id] => 8186469
[patent_doc_number] => 20120115773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'MODIFIED OMCI AS A COMPLEMENT INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 13/148045
[patent_app_country] => US
[patent_app_date] => 2010-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13241
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20120115773.pdf
[firstpage_image] =>[orig_patent_app_number] => 13148045
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/148045 | MODIFIED OMCI AS A COMPLEMENT INHIBITOR | Feb 3, 2010 | Abandoned |
Array
(
[id] => 9831877
[patent_doc_number] => 08940690
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-27
[patent_title] => 'Synthetic conjugates and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/145534
[patent_app_country] => US
[patent_app_date] => 2010-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 61547
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13145534
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/145534 | Synthetic conjugates and uses thereof | Jan 26, 2010 | Issued |
Array
(
[id] => 7587281
[patent_doc_number] => 20110281791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'CRYSTALLINE INSULIN-CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 13/145525
[patent_app_country] => US
[patent_app_date] => 2010-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 45528
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281791.pdf
[firstpage_image] =>[orig_patent_app_number] => 13145525
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/145525 | Crystalline insulin-conjugates | Jan 26, 2010 | Issued |
Array
(
[id] => 7567955
[patent_doc_number] => 20110288018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'BEVERAGE LOWERING SERUM CHOLESTEROL'
[patent_app_type] => utility
[patent_app_number] => 13/146282
[patent_app_country] => US
[patent_app_date] => 2010-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4883
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20110288018.pdf
[firstpage_image] =>[orig_patent_app_number] => 13146282
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/146282 | Beverage lowering serum cholesterol | Jan 25, 2010 | Issued |
Array
(
[id] => 9026722
[patent_doc_number] => 08536304
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-17
[patent_title] => 'Tumour-associated peptides that bind to MHC molecules'
[patent_app_type] => utility
[patent_app_number] => 12/632541
[patent_app_country] => US
[patent_app_date] => 2010-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 17
[patent_no_of_words] => 8893
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12632541
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/632541 | Tumour-associated peptides that bind to MHC molecules | Jan 21, 2010 | Issued |
Array
(
[id] => 8713473
[patent_doc_number] => 08399613
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-19
[patent_title] => 'Tumour-associated peptides that bind to MHC molecules'
[patent_app_type] => utility
[patent_app_number] => 12/632463
[patent_app_country] => US
[patent_app_date] => 2010-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 17
[patent_no_of_words] => 8894
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12632463
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/632463 | Tumour-associated peptides that bind to MHC molecules | Jan 21, 2010 | Issued |